Powered by Google-Search & Google-Books www.ChineseStandard.net Database: 169760 (Oct 23, 2021)
HOME   Quotation   Tax   Examples Standard-List   Contact-Us   Cart

GB/T 15670.21-2017 (GB/T15670.21-2017)

Standard IDContents [version]USDSTEP2[PDF] delivered inName of Chinese StandardSee DetailStatusRelated Standard
GB/T 15670.21-2017English165 Add to Cart 0--10 minutes. Auto-delivery. Toxicological test methods for pesticides registration -- Part 21: Unscheduled DNA synthesis (UDS) test with mammalian liver cells in vivo GB/T 15670.21-2017 Valid GB/T 15670.21-2017

GB/T 15670.21-2017: PDF in English (GBT 15670.21-2017)
GB/T 15670.21-2017
ICS 65.100
B 17
GB 15670.21-2017
Toxicological Test Methods for Pesticides Registration -
Part 21: Unscheduled DNA Synthesis (UDS) Test with
Mammalian Liver Cells in Vivo
ISSUED ON: JULY 12, 2017
Issued by: General Administration of Quality Supervision, Inspection and
Standardization Administration of PRC.
Table of Contents
Foreword ... 3
1 Scope ... 5
2 Normative References ... 5
3 Terms and Definitions ... 5
4 Purpose of the Test ... 6
5 Overview of the Test ... 6
6 Test Methods ... 6
7 Analysis and Evaluation of the Results ... 9
8 Test Report ... 10
Toxicological Test Methods for Pesticides Registration -
Part 21: Unscheduled DNA Synthesis (UDS) Test with
Mammalian Liver Cells in Vivo
1 Scope
This Part of GB/T 15670 specifies the basic principles, methods and requirements for
the unscheduled DNA synthesis (UDS) test of mammalian liver cells in vivo.
This part is applicable to unscheduled DNA synthesis (UDS) test with mammalian liver
cells in vivo for the pesticide registration.
2 Normative References
The following documents are essential to the application of this document. For the
dated documents, only the versions with the dates indicated are applicable to this
document; for the undated documents, only the latest version (including all the
amendments) is applicable to this document.
GB 14925 Laboratory Animal - Requirements of Environment and Housing
3 Terms and Definitions
For the purpose of this document, the following terms and definitions apply.
3.1 Unscheduled DNA synthesis; UDS
DNA synthesis that occurs in the S-phase of the cell cycle outside of semi-reserved
DNA synthesis.
3.2 Cell in repair
Cells with net nuclear grain higher than the historical negative control value of this
3.3 Net nuclear grain; NNG
weight variation shall not exceed ±20% of the average weight of the same sex. Use
the regular feed, and drinking water is not restricted. If the test substance is mixed into
feed for poisoning, an appropriate feed shall be selected to ensure that the test
substance is fully mixed. Animals may be raised individually or in groups of the same
sex. The breeding conditions of laboratory animals shall comply with the relevant
provisions of GB 14925.
6.1.2 Preparation before animal test
Before the test, the animals shall adapt to the environment of the laboratory animal
room for at least 5d. The animals are randomly divided into test substance group and
control group.
6.1.3 Preparation of test substance
The solid test substance shall be dissolved or suspended in an appropriate
solvent/excipient, and diluted before the animal is toxicant-exposed. The liquid test
substance may be directly toxicant-exposed, or diluted before being toxicant-exposed.
The test substance shall be prepared fresh, unless the stability data proves that it may
be stored.
6.1.4 Solvents/excipients
The solvent/excipient shall not produce toxic effects at the used dose level; and shall
not react with the test substance. If a solvent/excipient that is not fully understood is
used, there shall be information on its compatibility. It is recommended to consider the
use of aqueous solvents/excipients first.
6.1.5 Control
Each test shall include a simultaneous positive control and a negative
(solvent/excipient) control. Except for the different toxicant-exposure of the test
substance, the animals in the control group shall be operated in the same way as the
animals in the toxicant-exposed group.
The positive control shall expect an increase in UDS that exceeds the background
value at the exposure level. The dose of the positive control shall make the effect very
clear; but it does not make the reader immediately discover that it is the positive control
specimen. The route of toxicant-exposure of the positive control may be different from
that of the test substance. Commonly used positive control substances are shown in
Table 1.
used in limit test.
6.2.5 Toxicant-exposure
The test substance is usually given by gavage. If reasonable, other routes of toxicant-
exposure are also acceptable. The maximum liquid volume of one gavage does not
exceed 2mL/100g body weight. If a higher volume is used, the reason shall be
explained. In addition to the irritating or corrosive substances that have enhanced toxic
effects at higher concentrations, the concentration shall be adjusted to reduce the
volume of the test substance, and ensure that the volume is equal at all dose levels.
6.2.6 Preparation of liver cells
Liver cells are prepared 12h~16h after the animals are toxicant-exposed. If there is no
obvious positive reaction, take early-stage sampling (2h~4h after toxicant-exposure).
However, other sampling time may also be used based on the existing toxicokinetics
The liver is perfused in situ with collagenase, the liver cells are separated; and after
adherence, the mammalian liver cells are cultured for a short time. The survival rate of
liver cells in the negative control group shall be greater than 50%.
6.2.7 UDS determination
Newly separated mammalian liver cells are usually cultured in a 3H-TdR-containing
culture solution for an appropriate time, for instance, 3h~8h. At the end of the culture
period, after removing the culture medium, the cells are cultured in a culture solution
containing excessive unlabelled thymine to remove unincorporated radioactivity; this
operation may be omitted if the culture time is longer. Then, the cells were washed,
fixed, stained, and count the grains. Prepare 2~3 specimen slides for each animal.
7 Analysis and Evaluation of the Results
7.1 Analysis of the results
7.1.1 The specimen slide shall have enough cells with normal morphology for UDS
evaluation. Cytotoxicity (such as nuclear pyknosis, reduced radiolabel level) shall be
checked under a microscope.
7.1.2 Specimen slides shall be numbered before reading the slides. Each animal shall
be read at least 100 cells from 2 specimen slides. If each animal counts less than 100
cells, the reason shall be explained. Grains are not counted for S-phase nuclei, but the
proportion of S-phase cells shall be recorded.
7.1.3 Count the amount of 3H-TdR incorporated in the nucleus and cytoplasm of normal
b) The name and contact information of the test entrusting organization, the date of
sample acceptance and the situation of sample sealing;
c) The start and end date of the test, the person in charge of the test items, the
technical person in charge of the test organization, and the date of issuance;
d) Summary of test;
e) The name of the test substance, the active ingredient American Chemical
Abstracts Service accession number (CAS number) (if known), code (if any),
purity (or content), dosage form, production date (batch number), appearance
properties, and solvents and methods used for preparation;
f) The species, strain, grade, quantity, weight, gender, source (supplier name,
laboratory animal quality certificate number, laboratory animal production license
number) of laboratory animals; quarantine; adaptation conditions; and laboratory
animal breeding environment, including temperature, relative humidity, feed,
single cage breeding or group breeding, laboratory animal facility use permit
g) Dose and group, including the principle and basis for selecting the dose; the way
of animal grouping; and the number of animals of each gender in each group;
h) Test conditions and methods, including main instruments and equipment;
toxicant-exposure dose; route of toxicant-exposure; toxicant-exposure plan; test
cycle; observation indicators, etc.; positive control and negative
(solvent/excipient) control; and pre-test (if carried out) data of dose-related
design; method (if carried out) to prove that the test substance reaches the
systemic circulation or target organ; detailed description of the toxicant-exposure
and sampling plan; method of determining toxicity; preparation and culture
method of liver cells; autoradiography method; the number of prepared specimen
slides and the number of counted cells; the criteria for evaluation; and the criteria
for judging whether the test result is positive or negative;
i) Test results: Use the text description and table to summarize item by item of the
mean values of NG, CG and NNG of each specimen slide, each animal and each
group; dose-response relationship (if possible); statistical analysis (if any); and
toxicity performance. Simultaneous negative (solvent/excipient) control and
positive control data; background negative (solvent/excipient) control and
positive control data, including range, mean and standard deviation; and the
number of "cells in repair" (If determined); verify the criteria for the number of "
cells in repair" (if determined); the number of S-phase cells (if determined); cell
survival rate; and the rationality of the selection of statistical methods;
j) Test conclusion: Give the conclusion whether the test substance caused the
increase of unscheduled DNA synthesis of mammalian liver cells in vivo under
(Above excerpt was released on 2021-03-20, modified on 2021-06-07, translated/reviewed by: Wayne Zheng et al.)
Source: https://www.chinesestandard.net/PDF.aspx/GBT15670.21-2017